Goldman Sachs’s Bluescape Opportunities Acquisition Corp. Redeemable warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 BOAC.WS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-32,349
Closed -$33K 6949
2021
Q3
$33K Buy
+32,349
New +$36.1K ﹤0.01% 6116

Other funds holding BOAC.WS

Goldman Sachs's BOAC.WS Position: Q4 2021 in Review

Goldman Sachs sold out of Bluescape Opportunities Acquisition Corp. Redeemable warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 (BOAC.WS) in Q4 2021, closing a stake of 32,349 shares — an estimated $33K sold.

Goldman Sachs first reported a position in BOAC.WS in Q3 2021 and held it in 1 quarter. The position peaked at $33K in Q3 2021. 26 funds tracked by Wall St. Rank hold BOAC.WS as of Q4 2021.

  • Goldman Sachs reported no remaining Bluescape Opportunities Acquisition Corp. Redeemable warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 position as of Q4 2021 after selling out during the quarter.
  • Goldman Sachs sold 32,349 Bluescape Opportunities Acquisition Corp. Redeemable warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 shares in Q4 2021, an estimated $33K.
  • Goldman Sachs first reported a position in Bluescape Opportunities Acquisition Corp. Redeemable warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 in Q3 2021 and held it in 1 quarter.
  • Goldman Sachs's Bluescape Opportunities Acquisition Corp. Redeemable warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 position peaked at $33K in Q3 2021.
  • 26 funds tracked by Wall St. Rank held Bluescape Opportunities Acquisition Corp. Redeemable warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 as of Q4 2021.

Based on Goldman Sachs's 13F filing for Q4 2021, filed 14 Feb 2022.